Search
Close this search box.

Clinical Trial: ECOG-ACRIN EAY191-A3

ECOG-ACRIN EAY191-A3

Status: Open

Palbociclib and Binimetinib in RAS-Mutant Cancers: A ComboMATCH Treatment Trial
(See required screening study ECOG-ACRIN EAY191)

EAY191-A3 is temporarily closed to accrual to Cohort 3, effective May 7, 2024.